Quick Answer
Pharmagreen Biotech Inc. reported Common Stock Shares Outstanding of 442.26 million shares for the year ending 2022.
- Pharmagreen Biotech Inc. showed an increase of +16.0% in Common Stock Shares Outstanding from 2021 to 2022.
- This data is from Pharmagreen Biotech Inc.'s annual report (Form 10-K), filed with the SEC on January 17, 2023.
- XBRL data for this metric is available from 2018 to 2022 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: 74.67 million shares | Q4 2019: 75.65 million shares | Q1 2020: 75.72 million shares | Q2 2020: 91.15 million shares | Q1 2021: 348.17 million shares | Q2 2021: 355.13 million shares | Q4 2021: 385.17 million shares | Q1 2022: 397.22 million shares | Q2 2022: 424.42 million shares | Q3 2022: 442.26 million shares | Q4 2022: 454.76 million shares | Q1 2023: 454.76 million shares | Q2 2023: 463.96 million shares.
- Over the full 5 years of available data (2018 to 2022), Pharmagreen Biotech Inc.'s Common Stock Shares Outstanding has grown by 517.5%.
- Historical annual values: Fiscal year 2022: 442.26 million shares | Fiscal year 2021: 381.17 million shares | Fiscal year 2020: 95.81 million shares | Fiscal year 2019: 75.65 million shares | Fiscal year 2018: 71.62 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: